|
BE637389A
(https=)
*
|
1962-09-13 |
|
|
|
|
US4656187A
(en)
*
|
1981-08-03 |
1987-04-07 |
Eli Lilly And Company |
Treatment of mammary cancer
|
|
FI77839C
(fi)
|
1982-05-27 |
1989-05-10 |
Farmos Oy |
Foerfarande foer framstaellning av nya terapeutiskt effektiva trifenylalkan- och alkenderivat.
|
|
GB2126576B
(en)
*
|
1982-06-25 |
1985-06-19 |
Farmos Group Limited |
Alkane and alkene derivatives
|
|
US5491173A
(en)
*
|
1982-06-25 |
1996-02-13 |
Orion-Yhtyma Oy |
Tri-phenyl alkene derivatives and their preparation and use
|
|
US4729999A
(en)
*
|
1984-10-12 |
1988-03-08 |
Bcm Technologies |
Antiestrogen therapy for symptoms of estrogen deficiency
|
|
GB2196003A
(en)
|
1986-09-11 |
1988-04-20 |
Nat Res Dev |
Iodo-and bromo-tamoxifen derivatives
|
|
US4869155A
(en)
*
|
1988-07-11 |
1989-09-26 |
The Grieve Corporation |
Airflow distribution system for discharging air from a thin plenum, and oven employing same
|
|
US4977906A
(en)
*
|
1989-03-07 |
1990-12-18 |
Scipio William J Di |
Diurnal rehabilitation for incontinence trainer
|
|
US5189212A
(en)
*
|
1990-09-07 |
1993-02-23 |
University Of Georgia Research Foundation, Inc. |
Triarylethylene carboxylic acids with estrogenic activity
|
|
JPH06504522A
(ja)
|
1990-10-01 |
1994-05-26 |
ボード オブ リージェンツ， ザ ユニバーシティ オブ テキサス システム |
高親和性タモキシフェン誘導体とその使用
|
|
US6096874A
(en)
|
1990-10-01 |
2000-08-01 |
Board Of Regents, The University Of Texas System |
High affinity tamoxifen derivatives
|
|
US5219548A
(en)
*
|
1990-10-01 |
1993-06-15 |
Board Of Regents, The University Of Texas System |
High affinity halogenated-tamoxifen derivatives and uses thereof
|
|
US5118667A
(en)
*
|
1991-05-03 |
1992-06-02 |
Celtrix Pharmaceuticals, Inc. |
Bone growth factors and inhibitors of bone resorption for promoting bone formation
|
|
US5196435A
(en)
*
|
1991-11-21 |
1993-03-23 |
Eli Lilly And Company |
Melatonin derivatives and combinations with antiestrogen compounds for treating mammalian breast carcinoma
|
|
GB9207437D0
(en)
|
1992-04-03 |
1992-05-20 |
Orion Yhtymae Oy |
Topical administration of toremifene and its metabolites
|
|
US5446203A
(en)
*
|
1992-08-25 |
1995-08-29 |
New York University |
Synthesis of haloenones and aryl or alkyl substituted enones or alkenes
|
|
GB2273704B
(en)
|
1992-12-16 |
1997-01-22 |
Orion Yhtymae Oy |
Triazolyl diaryl selective aromatase inhibiting compounds
|
|
RU2077889C1
(ru)
*
|
1993-02-24 |
1997-04-27 |
Малое государственное предприятие "Флора" |
Способ лечения хронического простатита
|
|
DE4335876A1
(de)
*
|
1993-10-17 |
1995-04-20 |
Schering Ag |
Kombination von Progesteronantagonisten und Antiöstrogenen mit partialer agonistischer Wirkung für die Hormonsubstitutions-Therapie für peri- und postmenopausale Frauen
|
|
US5650425A
(en)
|
1994-04-04 |
1997-07-22 |
Pharmos Corporation |
Permanently ionic derivatives of steroid hormones and their antagonists
|
|
US5681835A
(en)
*
|
1994-04-25 |
1997-10-28 |
Glaxo Wellcome Inc. |
Non-steroidal ligands for the estrogen receptor
|
|
US5604248A
(en)
*
|
1994-05-05 |
1997-02-18 |
Eli Lilly And Company |
Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
|
|
US5470883A
(en)
*
|
1994-05-23 |
1995-11-28 |
Stromberg; Brent V. |
Method of treating peripheral vasoconstriction with tamoxifen citrate
|
|
US5441986A
(en)
*
|
1994-07-19 |
1995-08-15 |
Pfizer Inc. |
Estrogen agonists as remedies for prostate and cardiovascular diseases
|
|
GB9418067D0
(en)
|
1994-09-07 |
1994-10-26 |
Orion Yhtymae Oy |
Triphenylethylenes for the prevention and treatment of osteoporosis
|
|
US5658931A
(en)
*
|
1994-09-20 |
1997-08-19 |
Eli Lilly And Company |
Method for inhibiting mammalian breast carcinoma with tamoxifen, and analogs thereof, and certain naphthyl compounds
|
|
DE4435368A1
(de)
*
|
1994-09-22 |
1996-03-28 |
Schering Ag |
Verwendung von Aromatasehemmern zur Herstellung eines Arzneimittels zur Behandlung eines relativen Androgenmangels beim Mann
|
|
CN1167437A
(zh)
*
|
1994-11-29 |
1997-12-10 |
赫彻斯特马里恩鲁斯公司 |
用三芳基-乙烯衍生物治疗和预防骨质疏松的方法
|
|
US5821254A
(en)
*
|
1995-02-17 |
1998-10-13 |
The United States Of America As Represented By The Department Of Health And Human Services |
Uses of 9-cis-retinoic acids and derivatives thereof alone or in combination with antineoplastic agents in the prevention or treatment of cancer
|
|
GB9509572D0
(en)
|
1995-05-11 |
1995-07-05 |
Cancer Res Campaign Tech |
Cancer therapy
|
|
DE19526146A1
(de)
*
|
1995-07-07 |
1997-01-09 |
Schering Ag |
Triphenylethylene, Verfahren zu deren Herstellung, diese Triphenylethylene enthaltene pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
|
|
WO1997026876A1
(en)
|
1996-01-29 |
1997-07-31 |
Eli Lilly And Company |
Methods of increasing sphincter competence
|
|
GB9604577D0
(en)
|
1996-03-04 |
1996-05-01 |
Orion Yhtymae Oy |
Serum cholesterol lowering agent
|
|
JP2001502302A
(ja)
|
1996-09-19 |
2001-02-20 |
アメリカン・ホーム・プロダクツ・コーポレイション |
尿失禁を治療する方法
|
|
ZA982819B
(en)
*
|
1997-04-09 |
1999-10-04 |
Lilly Co Eli |
Treatment or prophylaxis of prostatic cancer and benign prostatic hyperplasia with selective estrogn receptor modulators.
|
|
US5972921A
(en)
*
|
1997-12-12 |
1999-10-26 |
Hormos Medical Oy Ltd. |
Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men
|
|
GB9803521D0
(en)
|
1998-02-19 |
1998-04-15 |
Orion Yhtymo Oy |
New compounds and pharmaceutical compositions thereof
|
|
US6413533B1
(en)
*
|
1998-05-07 |
2002-07-02 |
The University Of Tennessee Research Corporation |
Method for chemoprevention of prostate cancer
|
|
US6413535B1
(en)
*
|
1998-05-07 |
2002-07-02 |
The University Of Tennessee Research Corporation |
Method for chemoprevention of prostate cancer
|
|
US6465445B1
(en)
|
1998-06-11 |
2002-10-15 |
Endorecherche, Inc. |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
|
|
AU4701299A
(en)
*
|
1998-06-23 |
2000-01-10 |
Stuart R. Adler |
Therapeutic applications of estrogenic carboxylic acids
|
|
AU766648B2
(en)
*
|
1999-03-17 |
2003-10-23 |
Axys Pharmaceuticals, Inc. |
Compounds and methods for modulation of estrogen receptors
|
|
TW593256B
(en)
*
|
1999-11-16 |
2004-06-21 |
Hormos Medical Oy Ltd |
Triphenylalkene derivatives and their use as selective estrogen receptor modulators
|
|
WO2002003989A2
(en)
|
2000-07-06 |
2002-01-17 |
Wyeth |
Use of substituted indole compounds for treating sphincter incontinence
|
|
IL145838A
(en)
|
2000-10-16 |
2008-11-03 |
Pfizer Prod Inc |
Use of an estrogen agonist/antagonist for the manufacture of a medicament for treating vaginitis
|
|
RU2184543C1
(ru)
*
|
2001-05-24 |
2002-07-10 |
Московская медицинская академия им. И.М.Сеченова |
Способ лечения хронического простатита
|
|
JP4301763B2
(ja)
*
|
2001-10-31 |
2009-07-22 |
藤倉化成株式会社 |
銀化合物ペースト
|
|
JP2005512995A
(ja)
|
2001-11-09 |
2005-05-12 |
ファイザー ヘルス アーベー |
不安定又は過活動膀胱を治療するための抗ムスカリン剤及びエストロゲンアゴニスト
|
|
US20040248989A1
(en)
*
|
2003-06-05 |
2004-12-09 |
Risto Santti |
Method for the treatment or prevention of lower urinary tract symptoms
|